MARK1 antibody (C-Term)
Quick Overview for MARK1 antibody (C-Term) (ABIN2307859)
Target
See all MARK1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Cross-Reactivity
- Human
-
Cross-Reactivity (Details)
- Calculated cross reactivity: Hu
-
Characteristics
- MARK, CT (MARK1, KIAA1477, MARK, Serine/threonine-protein kinase MARK1, MAP/microtubule affinity-regulating kinase 1, PAR1 homolog c)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogen
- MARK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human MARK.
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C
-
-
- MARK1 (MAP/microtubule Affinity-Regulating Kinase 1 (MARK1))
-
Alternative Name
- MARK
-
NCBI Accession
- NP_061120
-
UniProt
- Q9P0L2
-
Pathways
- SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Target
-